Isotechnika Pharma Inc IPHAF

Back to normal trading

[snrkid]

In last couple weeks over 4 million shares were purged from people who did not want to hold.  That IMO is very healthy going forward.  Them shares are in hands who will hold for long term. 

At any and every angle you look at it, Voclosporine will be on the market and will become market leader.  There is no way of stopping it.  Roche or no Roche makes no difference.  Efficacy data and safety data are strong comparing to any possible combination from competition.   Generics regardless of pricing have no effect on use.  Any transplant recepient must have insurance or other third party payer due to cost of all drugs involved after transplant.  Any physician will prescribe drugs with best outcome, not cheapest which may kill. Calcineurin inhibitor is just one of them and with Voclosporine patient may even be able to live without some presently commonly used. Remember,  reduced side effects.

Any day within next 2-1/2 months.....$$
snrkid.